R&D

As Pfizer kills failed PhIII programs for Bavencio, where do they go from here in R&D?
Endpoints
Tue, 01/29/19 - 10:02 am
Pfizer
Bavencio
R&D
The antibiotics R&D effort is broken. Here's one market solution that might fix it
Endpoints
Fri, 01/25/19 - 11:51 am
R&D
antibiotics
Developing Drugs Is an Expensive Process. How Do Biopharma Companies Hope to Change That?
BioSpace
Mon, 01/21/19 - 11:58 pm
R&D
drug development
Pfizer once again takes out the budget ax and lops off 150 R&D staffers and 5 preclinical biosimilar drugs
Endpoints
Mon, 01/14/19 - 11:57 pm
Pfizer
R&D
biosimilars
layoffs
Hunting productivity, drugmakers pitch new 'pillars' of R&D
Biopharma Dive
Sat, 01/12/19 - 11:31 am
R&D
Moderna Therapeutics
Sarepta Therapeutics
Ionis Pharmaceuticals
Black Diamond Gets $85M for Cancer Drugs R&D and New Cambridge HQ
Xconomy
Thu, 01/10/19 - 09:45 am
Black Diamond Therapeutics
R&D
cancer
Rewiring R&D: The FierceBiotech JPM 2019 breakfast debate
Fierce Biotech
Wed, 01/9/19 - 12:58 pm
JPMHC 2019
R&D
artificial intelligence
machine learning
Ex-Juno execs launch cell therapy start-up Sana
BioCentury
Sat, 01/5/19 - 12:07 am
Sana Biotechnology
R&D
cell therapy
gene therapy
Juno Therapeutics
Selecta lays off staff as R&D cash crunch looms
Fierce Biotech
Fri, 01/4/19 - 10:05 am
Selecta Biosciences
layoffs
R&D
SEL-212
gout
Novartis shares data on discontinued antibiotic research
BioCentury
Thu, 01/3/19 - 11:42 pm
Novartis
R&D
antibiotics
Alphabet’s Biotech R&D Arm Verily Raises $1B to Fuel Growth
Xconomy
Thu, 01/3/19 - 11:41 pm
Verily
R&D
Google
Alphabet
The 2018 breakdown on a chart-topping set of new drug approvals — and the 5 big things we learned from it
Endpoints
Wed, 01/2/19 - 06:35 pm
R&D
drug approvals
FDA
Five Things To Look Out For In Cancer Research In 2019
Forbes
Mon, 12/31/18 - 12:06 pm
cancer
R&D
immunotherapy
liquid biopsy
microbiome
side effects
The French Biotech Industry Is Growing, With Focus on R&D and Big Data
BioSpace
Sat, 12/29/18 - 11:02 pm
France
biotech
R&D
Big Data
Boehringer offloads an mTOR cancer drug as Xynomic plots a quick advance in the clinic
Endpoints
Fri, 12/21/18 - 10:15 am
Boehringer Ingelheim
R&D
Xynomic
mTOR
Pharma R&D productivity hits new low amid rising costs
Pharmaforum
Wed, 12/19/18 - 10:12 am
R&D
drug development
Aiming to shed last-place rep, Eli Lilly touts its PhIII pipeline and promises a faster game in R&D
Endpoints
Wed, 12/19/18 - 10:06 am
Eli Lilly
R&D
Getting “Good Kills”: How Big Pharma Decides to End R&D Programs
BioSpace
Thu, 12/13/18 - 12:19 pm
R&D
Eisai, Takeda and GARDP hunt for new antibiotics
Pharmaforum
Wed, 12/12/18 - 09:54 am
Eisai
Takeda
GARDP
antibiotics
R&D
Pfizer to add 100 oncology R&D jobs, cut others amid restructure
Biopharma Dive
Wed, 12/12/18 - 12:09 am
Pfizer
layoffs
hirings
R&D
oncology

Pages